Dergiler / Annals of Medical Sciences / 2001 / Cilt: 10 - Sayı: 2

p53 Tumor supressor gene in laryngeal squamous cell carcinomas

Sayfa
55–58
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: This study may indicate that p53 gene mutation could have a role in laryngeal carcinoma, but the stage at which p53 has its effect on initiation or progression of this disease still remains unclear.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: Mutations in the p53 tumor supressor gene have been shown to be one of the most common genetic abnormalities in human cancers.
📊
Temel Bulgular & Veri:Using p53 avidin-biotin- complex immunohistochemical method on fixed, embedded specimens, the frequency of presence of mutant p53 protein was investigated to understand the role of the p53 gene mutations in tumorigenesis of the laryngeal carcinomas.
💡
Sonuç & Katkı:Conclusion: This study may indicate that p53 gene mutation could have a role in laryngeal carcinoma, but the stage at which p53 has its effect on initiation or progression of this disease still remains unclear.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Purpose: Mutations in the p53 tumor supressor gene have been shown to be one of the most common genetic abnormalities in human cancers. Using p53 avidin-biotin- complex immunohistochemical method on fixed, embedded specimens, the frequency of presence of mutant p53 protein was investigated to understand the role of the p53 gene mutations in tumorigenesis of the laryngeal carcinomas. Methods: Forty formalin fixed, paraffin embedded tumor specimens of squamous cell carcinoma of larynx comprised the patient group and 13 biopsy specimens of benign laryngeal nodule were used as controls. Immunohistochemical staining was applied to all specimens. Results: Abnormal expression of p53 protein was found in 19 of 40 laryngeal carcinomas (47.5 %). Mutant p53 protein was not found in any of the 13 cases with benign laryngeal nodules. There was no correlation between tumor size, nodal involvement, stage and abnormal expression of the p53 protein. However, a significant correlation was found between tumor grade and p53 expression. In all cases immunostaining of p53 within the malignant tumor cells was confined to the nuclei, and dysplastic epithelial areas also showed positive immunostaining in the nuclei of four cases. Conclusion: This study may indicate that p53 gene mutation could have a role in laryngeal carcinoma, but the stage at which p53 has its effect on initiation or progression of this disease still remains unclear.

🔖

Bu Makaleye Atıf Yap

AYDOĞAN, B., PAYDAŞ, S., KIROĞLU, M., YURDAKUL, H., SOYLU, L., GÖNLÜŞEN, G. (2022). p53 Tumor supressor gene in laryngeal squamous cell carcinomas. Annals of Medical Sciences, Cilt: 10 - Sayı: 2, 55–58. https://ajindex.com/articles/447474

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Levine AJ, Momand J, Finlay CA. The p53 tumour sup-pressor gene. Nature, 1991
  2. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jones AS, Gluckmann JL. The role of the p53 tumor sup-pressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 1993
  3. Ferlito A, Friedmann I. Squamous cell carcinoma. In: Ferkito A Ed. Neoplasms of the Larynx 1st ed. New York, N.Y.: Churchill Livingstone Inc.
  4. Haapasalo H, Isola J, Sallinen P, Kalimo H, Helin H, Rantala I. Aberrant p53 expression in astrocytic neo-plasms of the brain: Association with proliferation. Am J Pathol, 1993
  5. Baker SJ, Preisinger AC, Milburn Jessup J, Paraskeva C, Markowitz S, Wilson JK, Hamilton S, Vogelstein B. p53 Gene mutations occur in combination with 17p allelic de-letions as late events in colorectal tumorigenesis. Cancer Res, 1990
  6. Varley JM, Brammar WJ, Lane DP, Swallow JE, Dolan C, Walker RA. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Onco-gene, 1991
  7. Papadakis E, Malliri A, Linardopoulos S, Karaiossifidi H, Field JK, Spandidos DA. ras and p53 expression in non-small cell lung cancer patients: p53 over-expression cor-relates with a poor prognosis. Int J Oncol, 1992
  8. Chiba I, Takahashi T, Nau MM, D’Amico D, Curiel DT,Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 1990
  9. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Peluchi S, Barzan L, Grandi E, Boiocchi M. High frequency of p53 gene alterations associated with protein overexpres-sion in human squamous cell carcinoma of the larynx. Oncogene, 1992
  10. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, Kittas C. Expression of p53 protein in la-ryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Archiv, 1994
  11. Field JK, Malliri A, Butt SA, Gosney JR, Phillips D, Spondidos DA, Jones AS. p53 Overexpression in end stage squamous cell carcinomas of the head and neck cor-relates with a very poor clinical outcome. Int J Oncol, 1993
  12. Wynford TD. P53 in tumor pathology: Can we trust im-munohistochemistry?: editorial. J Pathol, 1992
  13. Dolcetti R, Doglioni, Maestro R, Gasparatto D, Barzan L,